Editorial: New trends in vascular biology 2024

Editorial: New trends in vascular biology 2024

Saved in:

Bibliographic Details
Main Authors:	Sarvesh Chelvanambi, Hong Chen, Margreet R. De Vries, Yun Fang, Gabrielle Fredman, Delphine Gomez, Hiroshi Iwata, Shizuka Uchida, Hiromi Yanagisawa, Masanori Aikawa
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	vascular disease cardiometabolic disease macrophage PCSK9 vascular imaging endothelial-mesenchymal transition
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2025.1649558/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Gain of function variants in PCSK9 gene in high risk patients after myocardial infarction with increased lipoprotein (a) values and treated with statins
by: Sabina Ugovšek, et al.
Published: (2025-07-01)

Causal relationship of familial hypercholesterolemia with risk of intestinal vascular disorders: A mendelian randomization study
by: Gang Wei, et al.
Published: (2025-03-01)

Vascular inflammation in chronic kidney disease: the role of uremic toxins in macrophage activation
by: Prabhash Kumar Jha, et al.
Published: (2025-03-01)

Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) to tackle central nervous system diseases: role as a promising approach
by: Xiaoxiao Zheng, et al.
Published: (2025-07-01)

Basic Vascular Science 2024 Meeting
by: Thijs J. Sluiter, MSc, et al.
Published: (2024-01-01)

PCSK9-antibodies fail to block PCSK9-induced inflammation in macrophages and cannot recapitulate protective effects of PCSK9-deficiency in experimental myocardial infarction
by: Simon Rauterberg, et al.
Published: (2025-01-01)

Circulating Endothelial Progenitor Cells in Patients with Established Cardiovascular Disease Treated with PCSK9 Monoclonal Antibodies
by: Chen Gurevitz, et al.
Published: (2024-12-01)

Modulation of atherogenesis biomarkers by PCSK9 inhibitors in Lp(a)-stimulated human coronary artery endothelial cells
by: Rahayu Zulkapli, et al.
Published: (2025-07-01)

PCSK9 inhibitors – new era of dyslipidemia treatment - effectiveness in reducing low-density lipoprotein (LDL-C) and cardiovascular risk
by: Radosław Szydłowski, et al.
Published: (2024-12-01)

Biosimilars in Retinal Diseases: A Primer
by: Rashmi Rawat, et al.
Published: (2024-04-01)

The vascular microenvironment and its stem cells regulate vascular homeostasis
by: Yanhui Wang, et al.
Published: (2025-03-01)

Immunotherapy and vaccine-based approaches for atherosclerosis prevention: a systematic review study
by: Mansoureh Shekarchizadeh Esfahani, et al.
Published: (2025-03-01)

Analysis of The Use of PCSK9 Inhibitors in Clinical Practice
by: S. Yu. Volkova, et al.
Published: (2023-03-01)

PCSK9 in T-cell function and the immune response
by: Yuying Wang, et al.
Published: (2024-12-01)

Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues
by: M. V. Zhuravleva, et al.
Published: (2020-09-01)

Effect of atorvastatin and rosuvastatin on the PCSK9 blood concentration in statin-naive patients with atherosclerosis
by: A. Yu. Filatova, et al.
Published: (2019-06-01)

Neutrophil–Endothelium Interaction Mediated by S100A9 Promotes Pulmonary Vascular Remodeling During Pulmonary Hypertension
by: Yu Guo, et al.
Published: (2025-08-01)

Ca2+ signaling in vascular smooth muscle and endothelial cells in blood vessel remodeling: a review
by: Yoshiaki Suzuki, et al.
Published: (2024-12-01)

Haemangioendothelioma of Different Sites: A Series of Four Cases
by: Reshma Rachel Alex, et al.
Published: (2025-05-01)

Regulatory mechanisms of hepatocyte PCSK9 expression: translating mechanistic insights into potential nutraceuticals
by: Seon Kyeong Park, et al.
Published: (2025-08-01)

СОХРАНЕНИЕ РЕЦЕПТОРОВ ЛПНП — НОВЫЙ ПОДХОД К ТЕРАПИИ ГИПЕРЛИПИДЕМИИ
by: С. С. Бажан
Published: (2013-12-01)

Relationship of sortilin and proprotein convertase subtilisin/kexin type 9 in blood serum with the severity of carotid and coronary atherosclerosis in hypertensive patients
by: Yu. Yu. Vukolova, et al.
Published: (2022-06-01)

Observational study of inclisiran effectiveness in Moscow healthcare
by: A. I. Sapina, et al.
Published: (2023-12-01)

Effectiveness of inclisiran lipid-lowering therapy in patients with atherosclerotic cardiovascular disease in Moscow healthcare
by: A. I. Sapina, et al.
Published: (2024-06-01)

PCSK9 Inhibitors: Focus on Evolocumab and Its Impact on Atherosclerosis Progression
by: Maram H. Abduljabbar
Published: (2024-11-01)

The infectious status of patients with Coats disease
by: N. V. Neroeva, et al.
Published: (2025-03-01)

Mechanisms of vascular aging
by: E. M. Stakhneva, et al.
Published: (2022-07-01)

Small Molecule Derived From Carboxyethylpyrrole Protein Adducts Promotes Angiogenesis in a Mouse Model of Peripheral Arterial Disease
by: Luqia Hou, et al.
Published: (2018-09-01)

Molecular mechanisms of endothelial–mesenchymal transition and its pathophysiological feature in cerebrovascular disease
by: Huimin Jiang, et al.
Published: (2025-04-01)

Integrins in Cardiovascular Health and Disease: Molecular Mechanisms and Therapeutic Opportunities
by: Karolina Ławkowska, et al.
Published: (2025-02-01)

Statin Intolerance and Adverse Effects in Lipid-Lowering Therapy – Pathomechanisms, Management Strategies, and Alternative Treatment Approaches
by: Natalia Śliwa, et al.
Published: (2025-06-01)

VASCULAR REMODELING IN HYPERTENSION: ANGIOGENESIS FEATURES
by: L. A. Haisheva, et al.
Published: (2014-07-01)

Vascular Aging in Ischemic Stroke
by: Lian Liu, et al.
Published: (2024-08-01)

Adult-onset Coats’ disease: a review
by: V. E. Tankovskiy, et al.
Published: (2024-10-01)

Treatment with PCSK9 inhibitors influences microRNAs expression and changes of arterial wall properties: a randomized controlled trial
by: Andreja Rehberger Likozar, et al.
Published: (2025-02-01)

High-Intensity Statins Promote PCSK9 Secretion and aortic valve calcification in patients with severe aortic stenosis: In vitro and clinical evidence
by: Veronika A. Myasoedova, et al.
Published: (2025-05-01)

The correlation between proprotein convertase subtilisin/kexin type 9 and adiponectin in the progression from prediabetes to type 2 diabetes mellitus
by: Jun-Xu Gu, et al.
Published: (2025-03-01)

Carotenoid Interactions with PCSK9: Exploring Novel Cholesterol-Lowering Strategies
by: Alessandro Medoro, et al.
Published: (2024-11-01)

Generalizability of VICTORION-1 PREVENT enrollment criteria to the United States population
by: Rahul Aggarwal, et al.
Published: (2025-06-01)

Successful Palmar Arch Revascularization of Thromboangiitis Obliterans in the Upper Extremity
by: Perihan Varim, MD, et al.
Published: (2025-07-01)